Roger P.M. Sutmuller

5.8k total citations · 2 hit papers
30 papers, 4.5k citations indexed

About

Roger P.M. Sutmuller is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Roger P.M. Sutmuller has authored 30 papers receiving a total of 4.5k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Immunology, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Roger P.M. Sutmuller's work include Immunotherapy and Immune Responses (20 papers), T-cell and B-cell Immunology (15 papers) and Immune Cell Function and Interaction (12 papers). Roger P.M. Sutmuller is often cited by papers focused on Immunotherapy and Immune Responses (20 papers), T-cell and B-cell Immunology (15 papers) and Immune Cell Function and Interaction (12 papers). Roger P.M. Sutmuller collaborates with scholars based in Netherlands, United States and Germany. Roger P.M. Sutmuller's co-authors include Gosse J. Adema, Rienk Offringa, Erik Bennink, René E. M. Toes, Leonie M. van Duivenvoorde, Andrea van Elsas, James P. Allison, Mihai G. Netea, Carl G. Figdor and Cornelis J.M. Melief and has published in prestigious journals such as Journal of Clinical Investigation, The Journal of Experimental Medicine and The Journal of Immunology.

In The Last Decade

Roger P.M. Sutmuller

30 papers receiving 4.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Synergism of Cytotoxic T Lymphocyte–Associated Antigen 4 Blockade and Depletion of Cd25+ Regulatory T Cells in Antitumor Therapy Reveals Alternative Pathways for Suppression of Autoreactive Cytotoxic T Lymphocyte Responses

2001 834 citations Roger P.M. Sutmuller, Leonie M. van Duivenvoorde et al. profile →
Toll-like receptor 2 controls expansion and function of regulatory T cells

2006 602 citations Roger P.M. Sutmuller Journal of Clinical Investigation profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roger P.M. Sutmuller Netherlands	24	3.4k	1.5k	773	474	361	30	4.5k
Matthias Schiemann Germany	35	3.1k 0.9×	1.2k 0.8×	1.1k 1.4×	675 1.4×	161 0.4×	68	4.5k
Jane L. Grogan United States	34	4.7k 1.4×	2.5k 1.7×	1.0k 1.3×	306 0.6×	207 0.6×	60	6.7k
Baogong Zhu United States	12	4.0k 1.2×	2.2k 1.4×	763 1.0×	873 1.8×	482 1.3×	15	5.5k
Danielle Lenig Switzerland	8	6.5k 1.9×	2.1k 1.4×	868 1.1×	862 1.8×	461 1.3×	8	7.7k
Rafael Cubas United States	24	2.4k 0.7×	1.1k 0.7×	688 0.9×	382 0.8×	349 1.0×	42	3.6k
Dirk G. Brockstedt United States	29	3.5k 1.0×	2.0k 1.3×	1.3k 1.7×	315 0.7×	230 0.6×	77	5.0k
Daniel M. Andrews Australia	31	3.9k 1.1×	1.5k 1.0×	805 1.0×	700 1.5×	253 0.7×	70	5.0k
Shahram Salek‐Ardakani United States	37	2.8k 0.8×	1.1k 0.7×	848 1.1×	463 1.0×	185 0.5×	70	3.9k
Edward E. Lemmens United States	16	4.5k 1.3×	1.4k 0.9×	1.3k 1.6×	429 0.9×	604 1.7×	23	5.2k
Julie Curtsinger United States	36	6.5k 1.9×	2.6k 1.7×	804 1.0×	827 1.7×	235 0.7×	74	7.6k

Countries citing papers authored by Roger P.M. Sutmuller

Since Specialization

Citations

This map shows the geographic impact of Roger P.M. Sutmuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger P.M. Sutmuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger P.M. Sutmuller more than expected).

Fields of papers citing papers by Roger P.M. Sutmuller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger P.M. Sutmuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger P.M. Sutmuller. The network helps show where Roger P.M. Sutmuller may publish in the future.

Co-authorship network of co-authors of Roger P.M. Sutmuller

This figure shows the co-authorship network connecting the top 25 collaborators of Roger P.M. Sutmuller. A scholar is included among the top collaborators of Roger P.M. Sutmuller based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger P.M. Sutmuller. Roger P.M. Sutmuller is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Amssoms, Katie, Ellen Van Gulck, Wouter L.J. Hinrichs, et al.. (2018). Ovalbumin-containing core-shell implants suitable to obtain a delayed IgG1 antibody response in support of a biphasic pulsatile release profile in mice. PLoS ONE. 13(8). e0202961–e0202961. 9 indexed citations

Sutmuller, Roger P.M., Gustavo Gers-Huber, Annette Audigé, et al.. (2012). Humanized Mice Recapitulate Key Features of HIV-1 Infection: A Novel Concept Using Long-Acting Anti-Retroviral Drugs for Treating HIV-1. PLoS ONE. 7(6). e38853–e38853. 64 indexed citations

Nierkens, Stefan, et al.. (2011). Multifaceted effects of synthetic TLR2 ligand and Legionella pneumophilia on Treg-mediated suppression of T cell activation. BMC Immunology. 12(1). 23–23. 15 indexed citations

Nierkens, Stefan, Martijn H. den Brok, Roger P.M. Sutmuller, et al.. (2008). In vivo Colocalization of Antigen and CpG within Dendritic Cells Is Associated with the Efficacy of Cancer Immunotherapy. Cancer Research. 68(13). 5390–5396. 47 indexed citations

Grauer, Oliver, Johan W. Molling, Erik Bennink, et al.. (2008). TLR Ligands in the Local Treatment of Established Intracerebral Murine Gliomas. The Journal of Immunology. 181(10). 6720–6729. 107 indexed citations

Sutmuller, Roger P.M., Anja Garritsen, & Gosse J. Adema. (2007). Regulatory T cells and toll-like receptors: regulating the regulators. Annals of the Rheumatic Diseases. 66. iii91–iii95. 55 indexed citations

Grauer, Oliver, Stefan Nierkens, Erik Bennink, et al.. (2007). CD4+FoxP3+ regulatory T cells gradually accumulate in gliomas during tumor growth and efficiently suppress antiglioma immune responses in vivo. International Journal of Cancer. 121(1). 95–105. 175 indexed citations

Sutmuller, Roger P.M.. (2006). Toll-like receptor 2 controls expansion and function of regulatory T cells. Journal of Clinical Investigation. 116(2). 485–494. 602 indexed citations breakdown →

Sutmuller, Roger P.M., Stefan Nierkens, Erik Bennink, et al.. (2006). Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity. British Journal of Cancer. 95(7). 896–905. 228 indexed citations

10.

Brok, Martijn H. den, Roger P.M. Sutmuller, Stefan Nierkens, et al.. (2006). Synergy between In situ Cryoablation and TLR9 Stimulation Results in a Highly Effective In vivo Dendritic Cell Vaccine. Cancer Research. 66(14). 7285–7292. 146 indexed citations

11.

Sutmuller, Roger P.M., Mary E. Morgan, Mihai G. Netea, Oliver Grauer, & Gosse J. Adema. (2006). Toll-like receptors on regulatory T cells: expanding immune regulation. Trends in Immunology. 27(8). 387–393. 161 indexed citations

12.

Netea, Mihai G., J.W.M. van der Meer, Roger P.M. Sutmuller, Gosse J. Adema, & Bart Jan Kullberg. (2005). From the Th1/Th2 Paradigm towards a Toll-Like Receptor/T-Helper Bias. Antimicrobial Agents and Chemotherapy. 49(10). 3991–3996. 141 indexed citations

13.

Netea, Mihai G., Roger P.M. Sutmuller, Corinna Hermann, et al.. (2004). Toll-Like Receptor 2 Suppresses Immunity against Candida albicans through Induction of IL-10 and Regulatory T Cells. The Journal of Immunology. 172(6). 3712–3718. 477 indexed citations

14.

Morgan, Mary E., et al.. (2004). CD25+ regulatory cells from HLA-DQ8 transgenic mice are capable of modulating collagen-induced arthritis. Human Immunology. 65(11). 1319–1327. 8 indexed citations

15.

Sutmuller, Roger P.M., Rienk Offringa, & Cornelis J.M. Melief. (2004). Revival of the regulatory T cell: new targets for drug development. Drug Discovery Today. 9(7). 310–316. 25 indexed citations

16.

Brok, Martijn H. den, Roger P.M. Sutmuller, Robbert van der Voort, et al.. (2004). In Situ Tumor Ablation Creates an Antigen Source for the Generation of Antitumor Immunity. Cancer Research. 64(11). 4024–4029. 346 indexed citations

17.

Morgan, Mary E., Roger P.M. Sutmuller, Leonie M. van Duivenvoorde, et al.. (2003). CD25+ cell depletion hastens the onset of severe disease in collagen‐induced arthritis. Arthritis & Rheumatism. 48(5). 1452–1460. 264 indexed citations

18.

Diehl, Linda, Annemieke Th. den Boer, Roger P.M. Sutmuller, et al.. (2001). Rejection of Intraocular Tumors by CD4+ T Cells Without Induction of Phthisis. The Journal of Immunology. 167(10). 5832–5837. 29 indexed citations

19.

Réa, Delphine, Menzo Havenga, Roger P.M. Sutmuller, et al.. (2001). Highly Efficient Transduction of Human Monocyte-Derived Dendritic Cells with Subgroup B Fiber-Modified Adenovirus Vectors Enhances Transgene-Encoded Antigen Presentation to Cytotoxic T Cells. The Journal of Immunology. 166(8). 5236–5244. 130 indexed citations

20.

Sutmuller, Roger P.M., Leonie M. van Duivenvoorde, John A. Tine, et al.. (2000). Adoptive T Cell Immunotherapy of Human Uveal Melanoma Targeting gp100. The Journal of Immunology. 165(12). 7308–7315. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact